Both in Pharmaceuticals
Stoke Therapeutics vs Agios Pharmaceuticals
Over the past year STOK returned +8.3% and AGIO returned −21.6%; their daily moves had a correlation of 0.20.
STOK +8.3% AGIO −21.6%Growth of $1, one year, split-adjusted
| Metric | STOK | AGIO |
|---|---|---|
| Price | $27.45 | $31.38 |
| Market cap | $1.77B | $1.87B |
| Today | +1.70% | +0.58% |
| 1 month | +12.6% | −1.1% |
| 6 months | −17.5% | +16.3% |
| Year to date | −13.5% | +15.3% |
| 1 year | +5.2% | −21.8% |
| Revenue growth (YoY) | +5.9% | +259.3% |
| Gross margin | 100.0% | 93.3% |
| Net margin | −654.3% | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | 62.8× | 19.1× |
| Net cash | $319.2M | $617.6M |
| Dividend yield | — | — |
| Volatility (60d) | 47.9% | 58.0% |
| Short % of float | 18.9% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).